The in vitro diagnostics (IVD) market in Australia and New Zealand is poised for significant growth over the forecast period of 2024 to 2032. With an anticipated Compound Annual Growth Rate (CAGR) of 5.4%, the market is set to expand, driven by various factors including technological advancements, increased healthcare investments, and the development of innovative diagnostic tools. This...